XML 11 R4.htm IDEA: XBRL DOCUMENT  v2.3.0.11
CONDENSED CONSOLIDATED STATEMENT OF CASH FLOWS (USD $)
 3 Months Ended 9 Months Ended
Jun. 30, 2011
Jun. 30, 2010
Jun. 30, 2011
Jun. 30, 2010
Cash Flows from Operating Activities:        
Net loss $ (267,787) $ (143,317) $ (522,377) $ (359,308)
Depreciation 2,850 1,666 8,550 6,666
Change in fair value of derivative liability 33,349   26,807  
Amortization of intangible asset 78,750   105,000  
Amortization of debt discount     85,876  
Stock issued for services     92,800  
(Increase) Decrease in accounts receivable 127,730 (69,117) 334,611 (44,589)
(Increase) Decrease in inventory (61,335) (57,666) (61,335) (57,666)
(Increase) Decrease in prepaid expenses 46,314 (4,895) 2,398 18,091
Increase (decrease) in accounts payable (121,755) 130,245 (279,884) 163,862
Increase (decrease) in accrued expenses (21,925) (7,913) (21,925) (7,913)
Increase (decrease) in accrued expenses - related parties 130,000 100,000 130,000 100,000
Increase (decrease) in accrued interest - others 45,104   73,429  
Increase (decrease) in accrued interest - related parties 12,711 12,244 38,127 37,668
Net Cash Used by Operating Activities 34,364 (58,273) 12,077 (143,189)
Proceeds from sale of common stock       74,586
Decrease of bank overdraft     (10,506)  
Borrowing of convertible debt 30,100 30,000 157,600 69,500
Payments on line of credit     (25,000)  
Net Cash Provided by Financing Activities 30,100 30,000 122,094 144,086
Net Increase in Cash 64,464 (28,273) 134,171 897
Cash - Beginning of Period 136,023 27,065 136,023 27,065
Cash - End of Period 136,023 27,065 136,023 27,065
Cash paid for interest expense 1,680 1,856 5,363 8,782
Cash paid for income taxes     $ 800 $ 800
Nonmonetary Transactions [Abstract]        
Nonmonetary Transactions Disclosure [Text Block]

SUPPLEMENTAL DISCLOSURE OF NON-CASH FINANCING ACTIVITIES:

In November the Company issued 80,000,000 shares of its common stock valued at $60,000 to Elasco's president, $10,000 was recorded as a bonus and $50,000 is prepaid salary to be expensed over six months beginning mid November 2010.

Issuance of convertible note payable of $3,150,000 for unpatented rebreather system technology.

In April the Company issued 68,000,000 shares of its common stock valued at $32,800 to Elasco's president and one employee, which was recorded as prepaid salary to be expensed through July 2011

.

During the quarter $187,000 of notes and $6,646 of accrued interest was converted into 614,101,002 shares of the Company's common stock.

On June 30, 2011, the President of the Company converted $1,000 of accrued salary into 1 share of Series A Preferred Stock.